Regional Antimicrobial Decolonization Strategy, Diltiazem and NOAC Bleeding Risk, siRNA Targeting Lp(a), and more

JAMA Editor’s Summary

Regional Antimicrobial Decolonization Strategy, Diltiazem and NOAC Bleeding Risk, siRNA Targeting Lp(a), and more

Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the , issue.

May 14, 2024

Listen on your favorite player Take me to this show’s page

ADVERTISEMENT

Newer →

Neurodevelopmental Outcomes After Antenatal Steroids, Sexual Orientation and Mortality, ILD Review, and more

← Older

Prostate Cancer Screening, Clinical Outcomes for Cancer Drugs Granted Accelerated Approval, Lupus Review, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Regional Antimicrobial Decolonization Strategy, Diltiazem and NOAC Bleeding Risk, siRNA Targeting Lp(a), and more

Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the May 14, 2024, issue.

ADVERTISEMENT

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

00:00

00:00